National Health Investors (NHI) Scheduled to Post Quarterly Earnings on Monday

National Health Investors (NYSE:NHIGet Rating) is scheduled to be releasing its earnings data after the market closes on Monday, August 8th. Analysts expect National Health Investors to post earnings of $1.21 per share for the quarter. National Health Investors has set its FY 2022 guidance at $4.32-$4.42 EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

National Health Investors (NYSE:NHIGet Rating) last posted its quarterly earnings data on Monday, May 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing the consensus estimate of $0.63 by ($0.45). The company had revenue of $71.33 million during the quarter, compared to the consensus estimate of $73.06 million. National Health Investors had a net margin of 29.35% and a return on equity of 5.55%. The company’s revenue was down 11.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.24 earnings per share. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Trading Up 1.3 %

NHI opened at $64.84 on Monday. The stock has a market capitalization of $2.97 billion, a P/E ratio of 35.24 and a beta of 0.88. National Health Investors has a 12 month low of $50.22 and a 12 month high of $69.22. The firm’s fifty day simple moving average is $60.46 and its 200 day simple moving average is $57.49. The company has a current ratio of 23.40, a quick ratio of 23.40 and a debt-to-equity ratio of 0.84.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 5th. Investors of record on Thursday, June 30th will be given a $0.90 dividend. The ex-dividend date is Wednesday, June 29th. This represents a $3.60 annualized dividend and a yield of 5.55%. National Health Investors’s dividend payout ratio is currently 195.65%.

Analyst Ratings Changes

Several equities research analysts have commented on NHI shares. Credit Suisse Group started coverage on shares of National Health Investors in a research report on Wednesday, June 22nd. They set an “underperform” rating on the stock. BMO Capital Markets cut shares of National Health Investors from an “outperform” rating to a “market perform” rating and set a $62.00 price target on the stock. in a research report on Tuesday, June 21st. Finally, Capital One Financial started coverage on shares of National Health Investors in a research report on Friday, June 3rd. They set an “overweight” rating and a $64.00 price target on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $60.25.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently modified their holdings of NHI. First Republic Investment Management Inc. bought a new stake in shares of National Health Investors in the 1st quarter valued at about $204,000. Toroso Investments LLC bought a new stake in shares of National Health Investors in the 1st quarter valued at about $215,000. PNC Financial Services Group Inc. raised its holdings in shares of National Health Investors by 29.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the real estate investment trust’s stock valued at $300,000 after purchasing an additional 1,150 shares during the period. Penserra Capital Management LLC raised its holdings in shares of National Health Investors by 28.9% in the 1st quarter. Penserra Capital Management LLC now owns 5,293 shares of the real estate investment trust’s stock valued at $312,000 after purchasing an additional 1,188 shares during the period. Finally, Raymond James Financial Services Advisors Inc. raised its holdings in shares of National Health Investors by 5.7% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 6,806 shares of the real estate investment trust’s stock valued at $402,000 after purchasing an additional 368 shares during the period. 63.53% of the stock is owned by institutional investors.

About National Health Investors

(Get Rating)

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.